News
While the anti-IL-23p19 class dominates IBD advancements, ECCO 2025 will also spotlight emerging pipeline therapies, particularly OSE Immunotherapeutics’ IL-7R antagonist, lusvertikimab (OSE127).
Elev 548 ft, 41.88 °N, 87.63 °W Chicago, IL Weather Conditions star_ratehome ...
Elev 712 ft, 41.58 °N, 87.78 °W Tinley Park, IL Weather Conditions star_ratehome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback